BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3946507)

  • 21. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports].
    Rigal D; Juron-Dupraz F; Biggio B; Jouvenceaux A
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):101-4. PubMed ID: 7071459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
    Schönitzer D
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous umbilical blood sampling in the management of Kell isoimmunization.
    Copel JA; Scioscia A; Grannum PA; Romero R; Reece EA; Hobbins JC
    Obstet Gynecol; 1986 Feb; 67(2):288-90. PubMed ID: 3945439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
    Huang HJ; Tagawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative chromatographic-spectrophotometric determination of unconjugated bilirubin in the urine of newborn infants after phototherapy and in the amniotic fluid in cases of Rhesus incompatible pregnancies].
    Weiss PA; Rosanelli K
    Wien Klin Wochenschr; 1972 Oct; 84(40):621-7. PubMed ID: 4637399
    [No Abstract]   [Full Text] [Related]  

  • 28. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fetal erythroblastosis in Kell incompatibility].
    Fuith LC; Bichler A; Schönitzer D
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):131-3. PubMed ID: 3471624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kell hemolytic disease of the newborn: A case for expanded prenatal antibody screening.
    Spivey MA; Wilson JT; Taylor HL
    J Ark Med Soc; 1978 Jul; 75(2):73-5. PubMed ID: 149785
    [No Abstract]   [Full Text] [Related]  

  • 32. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
    Gottvall T; Hildén JO; Selbing A
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kell alloimmunization in pregnancy].
    Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
    J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rh-D antibody titer in amniotic fluids. Its use as an index of the severity of erythroblastosis fetalis.
    Usategui-Gomez M; Stearns SB; Toolan HW
    Am J Obstet Gynecol; 1969 Dec; 105(8):1238-46. PubMed ID: 4982810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First case of hemolytic disease of the newborn due to anti-Ula antibodies.
    Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M
    Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.